Hess Sanctions Uaru Development Offshore Guyana
Uaru development on Stabroek Block receives government approval with production targeted to begin in 2026…
Uaru development on Stabroek Block receives government approval with production targeted to begin in 2026…
Uaru project receives government approvals; production targeted to begin in 2026 Fifth Stabroek block development…
The Black-founded PE firm continues its commitment to hiring a diverse leadership team CHICAGO–(BUSINESS WIRE)–Please…
Revenue up 42% in 2022 to $6.0 million Primarily from Asset Monitoring with Constellation-as-a-Service Business…
VISTA, Calif.–(BUSINESS WIRE)–Flux Power Holdings, Inc. (NASDAQ: FLUX), a developer of advanced lithium-ion energy storage…
The transaction has a minimum cash condition of $100 million, including funds from the Arrowroot…
SAN ANTONIO–(BUSINESS WIRE)–NuStar Energy L.P. (NYSE: NS) today announced that its Board of Directors has…
SALT LAKE CITY–(BUSINESS WIRE)–Bridge Net Lease announced that it has acquired an off-market manufacturing asset…
SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Webcast Conference Call Friday, April 28, 2023, at 8:30 a.m. ET BRISBANE, Calif., April 27,…
DALLAS, April 27, 2023 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage…
RADNOR, Pa., April 27, 2023 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage…
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…
WOODCLIFF LAKE, N.J., April 27, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (“Eagle” or the…
SOUTH SAN FRANCISCO, Calif., April 27, 2023 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or…
GENFIT Announces Publication of Extra-Financial Performance Report 2022 Lille (France); Cambridge, (Massachusetts, United States); Zurich…
RICHMOND, Va.–(BUSINESS WIRE)–The Board of Directors of NewMarket Corporation (NYSE: NEU) declared a quarterly dividend…
CAMBRIDGE, Mass., April 27, 2023 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage…
SOUTH SAN FRANCISCO, Calif., April 27, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS,…
SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) — Telesis Bio (Nasdaq: TBIO), a leader in automated…